Wolverine Trading
CRMD icon

Wolverine Trading’s CorMedix CRMD Stock Holding History

Wolverine Trading’s Portfolio CRMD Stock Details CRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-78,000
Closed -$975K – 5698
2025
Q2 		$975K Sell
78,000
-14,100
-15% -$156K ﹤0.01% 2333
2025
Q1 		$621K Buy
92,100
+700
+0.8% +$7.25K ﹤0.01% 2725
2024
Q4 		$740K Buy
91,400
+33,000
+57% +$330K ﹤0.01% 2975
2024
Q3 		$470K Buy
58,400
+4,900
+9% +$26.5K ﹤0.01% 3120
2024
Q2 		$232K Buy
+53,500
New +$272K ﹤0.01% 3690
2023
Q3 		– Sell
-16,900
Closed -$66.6K – 4579
2023
Q2 		$66.6K Sell
16,900
-2,400
-12% -$11.9K ﹤0.01% 3880
2023
Q1 		$80K Buy
19,300
+6,100
+46% +$25K ﹤0.01% 3717
2022
Q4 		$56K Sell
13,200
-23,800
-64% -$84.2K ﹤0.01% 3556
2022
Q3 		$104K Buy
37,000
+17,700
+92% +$73.6K ﹤0.01% 3899
2022
Q2 		$69K Buy
19,300
+2,300
+14% +$8.54K ﹤0.01% 3963
2022
Q1 		$99K Buy
17,000
+3,200
+23% +$14.7K ﹤0.01% 4829
2021
Q4 		$65K Buy
+13,800
New +$68.5K ﹤0.01% 5244
2021
Q3 		– Sell
-23,000
Closed -$164K – 6349
2021
Q2 		$164K Buy
23,000
+800
+4% +$6.37K ﹤0.01% 5148
2021
Q1 		$200K Buy
+22,200
New +$234K ﹤0.01% 5051
2020
Q1 		– Sell
-15,200
Closed -$104K – 4709
2019
Q4 		$104K Buy
+15,200
New +$92.9K ﹤0.01% 4267
2019
Q3 		– Sell
-32,300
Closed -$290K – 4416
2019
Q2 		$290K Sell
32,300
-5,300
-14% -$41.6K ﹤0.01% 3297
2019
Q1 		$355K Buy
+37,600
New +$339K ﹤0.01% 3168
2016
Q4 		– Sell
-3,320
Closed -$42K – 4519
2016
Q3 		$42K Buy
+3,320
New +$31K ﹤0.01% 4418

Other funds holding CRMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wolverine Trading's CRMD Position: Q2 2025 in Review

Wolverine Trading sold out of CorMedix (CRMD) in Q2 2025, closing a stake of 45,937 shares — an estimated $507K sold.

Wolverine Trading first reported a position in CRMD in Q4 2019 and held it in 18 quarters. The position peaked at $365K in Q3 2024. 172 funds tracked by Wall St. Rank hold CRMD as of Q2 2025.

  • Wolverine Trading reported no remaining CorMedix position as of Q2 2025 after selling out during the quarter.
  • Wolverine Trading sold 45,937 CorMedix shares in Q2 2025, an estimated $507K.
  • Wolverine Trading first reported a position in CorMedix in Q4 2019 and held it in 18 quarters.
  • Wolverine Trading's CorMedix position peaked at $365K in Q3 2024.
  • 172 funds tracked by Wall St. Rank held CorMedix as of Q2 2025.

Based on Wolverine Trading's 13F filing for Q2 2025, filed 18 Aug 2025.